ClinicalTrials.gg
Not yet recruitingNCT07744594Updated Aug 4, 2026

Study on Dynamic Multimodal Analgesia Regimen Integrated With Traditional Chinese and Western Medicine After Perianal Abscess Surgery

An interventional study of TCM sitz bath in Perianal Abscess, sponsored by The Affiliated Hospital of Putian University. Not yet recruiting at 1 site in China. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-08-04.

Sponsored by The Affiliated Hospital of Putian University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Jul 2026, 3 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
147
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

Background:Perianal abscess is a common acute anorectal pyogenic disease (8%-25% of anorectal illnesses), mainly seen in men aged 20-40. Over 90% suffer severe postoperative pain, impairing healing, triggering anxiety or sepsis and raising medical loads. Western multimodal analgesia eases pain yet causes dependence and side effects. TCM sitz baths clear heat, reduce swelling and promote recovery. Few personalized combined protocols are available, and integrated Chinese-Western synergies are insufficiently exploited. This optimized integrated intervention guides postoperative pain nursing.

02

Conditions studied

  • Perianal Abscess

Browse trials for

03

In context

Abscess

152 studies on the registry are indexed under Abscess; 22 are open to participants now.

This study's planned enrollment of 147 is above the median of 110 across 120 interventional studies indexed under Abscess.

Browse Abscess studies →

Lead sponsor

The Affiliated Hospital of Putian University is the lead sponsor of 14 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Aged between 18 and 75 years old (18 ≤ age ≤ 75);
  2. Diagnosed with primary perianal abscess via digital rectal examination, anorectal ultrasound or MRI, and scheduled for incision and drainage or radical surgery;
  3. The maximum diameter of the abscess cavity ≥ 2 cm, or with obvious abscess cavity formation;
  4. Patients are willing and capable of participating in the pain management protocol, fully understand the significance of pain management, and can actively cooperate with study procedures;
  5. No severe coagulation disorders.

Exclusion criteria

Exclusion Criteria:

  1. Complicated with specific infectious diseases such as Crohn's disease and tuberculosis;
  2. Unclear source of postoperative pain, i.e., the origin of pain cannot be confirmed or the pain is unrelated to surgery;
  3. Presence of definite , including drug allergy or inability to tolerate any pain management measures adopted in this trial;
  4. Pregnant or lactating women;
  5. Patients unable to cooperate with the study, such as those with cognitive impairment, history of mental illness, communication barriers and other conditions;
  6. Patients with long-term analgesic medication use and established drug tolerance;
  7. Complicated with uncontrolled cardiovascular and cerebrovascular diseases ( cardiac function class Ⅲ-Ⅳ), hepatic and renal insufficiency ( class C or \< 30 mL/min/1.73 m²), etc.;
  8. Abscess secondary to rectal neoplasms, trauma or iatrogenic injury;
  9. Severe postoperative complications (such as massive hemorrhage, sepsis) or concurrent infections at other sites;
  10. Patients receiving only non-surgical treatments such as simple needle aspiration of pus.
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

NYHA class (heart failure)

The New York Heart Association’s four classes of how much heart failure limits physical activity.

I
No limits: ordinary activity causes no undue tiredness or breathlessness.
II
Slight limits: comfortable at rest, ordinary activity causes symptoms.
III
Marked limits: comfortable at rest, less than ordinary activity causes symptoms.
IV
Symptoms even at rest; any activity makes them worse.

Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.

Child-Pugh class

A score of how well the liver works in people with liver disease such as cirrhosis: class A is mild, B moderate and C severe.

GFR and eGFR (kidney filtering)

GFR (glomerular filtration rate) is how much blood the kidneys filter each minute. It is usually estimated from a blood test — eGFR, by formulas such as CKD-EPI or MDRD — and some studies ask for it to be measured directly instead. Usually given in mL/min/1.73 m².

Check the method, the units and the minimum the study states. A value of 90 or above is in the normal-or-high range, but kidney damage can show in other tests too.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
147 participants (estimated)

Study arms

  • Other
    Western Multimodal Analgesia Group

    Western multimodal analgesia. Dynamic whole-course NRS evaluation was performed: baseline measurement preoperatively, regular rest/activity pain checks and breakthrough pain assessment postoperatively, plus follow-up reassessment after discharge. Stepwise stratified medication was applied alongside non-pharmacological measures including potassium permanganate sitz bath, health education and psychological counseling. A pain management team adjusted regimens individually via daily ward rounds.

    Other: TCM sitz bath

  • Experimental
    Integrated Traditional Chinese and Western Medicine Multimodal Analgesia Group

    integrated Chinese-Western multimodal analgesia. All interventions of Group B were adopted, with additional TCM sitz bath and TCM nursing; assessment and Western medicine protocols remained identical to Western Multimodal Analgesia Group

    Other: TCM sitz bath

Interventions

  • OtherTCM sitz bath

    TCM sitz bath

06

What researchers measure

Primary outcomes

  1. Numerical Rating Scale,NRS

    The Numerical Rating Scale (NRS) for pain assessment ranges from 0 to 10, with higher scores indicating more severe pain and poorer outcomes.

    Time frame: Postoperative days 1, 2, 3, 4, 5, 2 weeks and 1 month

  2. total postoperative analgesic consumption

    Total consumption of analgesics was converted to morphine equivalent daily dose (MEDD) for intergroup comparison.

    Time frame: Postoperative days 1, 2, 3, 4, 5, 2 weeks and 1 month

  3. postoperative quality of life indicators

    The Short-Form 36 (SF-36) Health Survey was employed to evaluate quality of life, with each domain scored from 0 (minimum) to 100 (maximum), and higher scores reflecting more favorable health status and better quality of life.

    Time frame: at day 3 and month 1 postoperatively

Secondary outcomes

  1. postoperative urinary retention

    Patients were placed in the supine position with a moderately full bladder. The ultrasound probe was positioned above the pubic symphysis, and the anteroposterior, transverse, and longitudinal diameters of the bladder were measured. The post-void residual urine volume was calculated using the formula: bladder volume (mL) ≈ 0.52 × length × width × height (cm). A residual volume of \<50 mL was considered normal, 50-200 mL indicated mild urinary retention or impaired voiding, and \>200 mL was diagnostic of postoperative urinary retention. Complete inability to void with a bladder volume of \>400 mL was defined as acute urinary retention.

    Time frame: 24 hours postoperatively

  2. secondary hemorrhage

    Active oozing from the surgical wound occurring beyond 24 hours postoperatively, with a blood loss of ≥5 mL, requiring dressing change and continuous compression hemostasis with sterile gauze; secondary suturing is indicated if bleeding cannot be controlled.

    Time frame: 24 hours postoperatively

  3. perianal edema

    Perianal edema was defined as visible significant soft-tissue swelling around the operative site, accompanied by local tenderness, with the edema persisting for more than 72 hours.

    Time frame: within 72 hours postoperatively

  4. assessment of sexual function

    Erectile function in male patients was evaluated using the International Index of Erectile Function-5 (IIEF-5), which has a total score ranging from 5 (minimum) to 25 (maximum), with higher scores denoting better erectile function. For female patients, sexual function was assessed using the Female Sexual Function Index (FSFI), with total scores ranging from 2 to 36, where a higher score indicates better sexual function.

    Time frame: assessed preoperatively and at 1 month postoperatively

07

Study locations

1 site
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jul 2026; primary completion for Jul 2026, 0 months later.

Of 21 interventional studies with no phase under Abscess, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 56. This study's planned 0 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 16, 2026
First posted
Aug 4, 2026
StartEst.
Jul 30, 2026
Primary completionEst.
Jul 30, 2026
CompletionEst.
Jul 30, 2026
Last update
Aug 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07744594
Lead sponsor
The Affiliated Hospital of Putian University
Responsible party
Sponsor
First posted
Aug 4, 2026
Start date
Jul 30, 2026 (estimated)
Primary completion
Jul 30, 2026 (estimated)
Completion
Jul 30, 2026 (estimated)
Last update
Aug 4, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion